Biodesix Inc. (BDSX) Misses Q4 EPS by 7c

Biodesix Inc. (NASDAQ: BDSX) reported Q4 EPS of ($0.35), $0.07 worse than the analyst estimate of ($0.28). Revenue for the quarter came in at $9.61 million versus the consensus estimate of $10.77 million.

For earnings history and earnings-related data on Biodesix Inc. (BDSX) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Algorhythm Holdings (RIME) Tops Q2 EPS by 54c
• Movano (MOVE) Misses Q2 EPS by 195c